Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity
Open accessThe DOI matches its Crossref record.
Abstract
Objective This study was conducted to determine whether increased body mass index (BMI) affects oral contraceptive (OC) pharmacokinetics and suppression of hypothalamic-pituitary-ovarian (HPO) axis activity. Study design Ovulatory reproductive-age women of normal (< 25 kg/m2; n = 10) and obese (> 30 kg/m2; n = 10) BMI received OCs for two cycles (prospective cohort). Subjects were admitted for two 48-h inpatient stays at the beginning and end of the hormone-free interval. Ethinyl estradiol (EE) and levonorgestrel (LNG) levels were evaluated during both inpatient stays. Gonadotropin pulsatility (FSH and LH) was measured during the second inpatient stay. Estradiol (E2) and progesterone (P) were measured daily during inpatient stays and twice per week in Cycle 2. Results BMI was greater in the obese, compared to the normal BMI group [37.3 kg/m2 (SD 6.0) versus 21.9 kg/m2 (SD 1.6); p < 0.05]. The LNG half-life was significantly longer in the obese group (52.1 ± 29.4 h versus 25.6 ± 9.3 h, p < 0.05) which correlated with a lower maximum LNG concentration on Cycle 2, Day 1 [1.9 ng/mL (SD 0.5) versus 2.5 ng/mL (SD 0.7)] and a longer time to reach steady-state (10 versus 5 days), in obese women. There were no significant differences in volume of distribution between groups. LH pulse parameters did not differ statistically between groups but trended towards greater HPO activity in the obese group. Additionally, more obese (6/10 versus 3/10 normal BMI, p > 0.05) women exhibited E2 levels consistent with development of a dominant follicle, and P levels consistent with ovulation (2/10 versus 1/10) during Cycle 2. Conclusions Compared to women of normal BMI, obese women exhibit differences in OC pharmacokinetics that are associated with greater HPO activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glasier, A., Cameron, S. T., Blithe, D., Scherrer, B., Mathe, H., Levy, D., Gainer, E., & Ulmann, A. (2011) · Contraception · doi:10.1016/j.contraception.2011.02.009 · Cited by 303
Sitruk-Ware, R., & Nath, A. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.09.004 · Cited by 247
Metabolic effects of contraceptive steroids
Sitruk-Ware, R., & Nath, A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9182-4 · Cited by 161
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003072 · Cited by 147
Jacobsen, L. V., Vouis, J., Hindsberger, C., & Zdravkovic, M. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010389471 · Cited by 41
Metadata
- Authors
- Edelman, A. B., Carlson, N. E., Cherala, G., Munar, M. Y., Stouffer, R. L., Cameron, J. L., Stanczyk, F. Z., & Jensen, J. T.
- Venue
- Contraception
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 80
- Issue
- 2
- Pages
- 119-127
- ISSN
- 0010-7824 (ISSN-L)
- OpenAlex
- W2111990384
- Cited by
- 132
- References
- 0
- FWCI
- 11.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity. https://app.cochat.ai/papers/10.1016/j.contraception.2009.04.011
- The paper
- Edelman, A. B., Carlson, N. E., Cherala, G., Munar, M. Y., Stouffer, R. L., Cameron, J. L., Stanczyk, F. Z., & Jensen, J. T. (2009). Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity. Contraception. https://doi.org/10.1016/j.contraception.2009.04.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.